Effect of Incisional Negative Pressure Wound Therapy vs Standard Wound Dressing on Deep Surgical Site Infection After Surgery for Lower Limb Fractures Associated With Major Trauma: The WHIST Randomized Clinical Trial.
Journal article
Costa ML. et al, (2020), JAMA, 323, 519 - 526
Autofluorescence Lifetime Reports Cartilage Damage in Osteoarthritis.
Journal article
Lagarto JL. et al, (2020), Sci Rep, 10
Single cell force profiling of human myofibroblasts reveals a biophysical spectrum of cell states.
Journal article
Layton TB. et al, (2020), Biol Open
Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis.
Journal article
Izadi D. et al, (2019), Sci Adv, 5
A successful strategy for recruiting participants not in a care pathway to a CTIMP on time and to target
Conference paper
Francis A. et al, (2019), TRIALS, 20
Recent advances in the understanding of Dupuytren's disease.
Journal article
Layton T. and Nanchahal J., (2019), F1000Res, 8
Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial.
Journal article
Nanchahal J. et al, (2018), EBioMedicine, 33, 282 - 288
Standard wound management versus negative-pressure wound therapy in the treatment of adult patients having surgical incisions for major trauma to the lower limb-a two-arm parallel group superiority randomised controlled trial: protocol for Wound Healing in Surgery for Trauma (WHIST).
Journal article
Achten J. et al, (2018), BMJ Open, 8
Fully reduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert.
Journal article
Lee G. et al, (2018), Proc Natl Acad Sci U S A, 115, E4463 - E4472
HMGB1 accelerates regeneration of multiple tissues by transitioning stem cells to G(Alert)
Conference paper
Lee G. et al, (2018), AUSTRALASIAN JOURNAL OF DERMATOLOGY, 59, 83 - 83
Method of treating a localized fibrotic disorder using an IL-33 antagonist
Patent
NANCHAHAL J. et al, (2018)
What do we know about managing Dupuytren's disease cost-effectively?
Journal article
Dritsaki M. et al, (2018), BMC Musculoskelet Disord, 19
Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD).
Journal article
Png ME. et al, (2018), Wellcome open research, 3
Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD).
Journal article
Png ME. et al, (2018), Wellcome Open Res, 3
HMGB1 Accelerates Regeneration of Multiple Tissues By Transitioning Stem Cells to G(Alert)
Conference paper
Lee G. et al, (2017), BLOOD, 130
HMGB1 accelerates regeneration of multiple tissues by transitioning stem cells to G(Alert)
Conference paper
Lee G. et al, (2017), JOURNAL OF BONE AND MINERAL RESEARCH, 32, S48 - S48
Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren’s disease, with an embedded dose response study.
Journal article
Nanchahal J. et al, (2017)
A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis.
Journal article
Ng M. et al, (2017), Am J Hum Genet, 101, 417 - 427
Does negative-pressure wound therapy influence subjacent bacterial growth? A systematic review.
Journal article
Glass GE. et al, (2017), J Plast Reconstr Aesthet Surg, 70, 1028 - 1037